A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

Profiles >> Frieda Hernandez Archives

Patient-Powered Collaboration: ALD Connect Launches a Doctor-Patient Webinar Series

Posted by | 3:14pm on Wednesday, November 5, 2014 | No Comments
logo_ald

The ALD Connect website offers a great video that explains ALD 

As part of our ongoing focus on multi-stakeholder collaboration in the rare disease space, we are highlighting successful and unique examples of this programming to improve patient outcomes. ALD Connect is a Patient-Powered Research Network (PPRN) consortium composed of ALD patients, patient advocates, and researchers supported in part by the Patient-Centered Outcomes Research Institute (PCORI). The mission of the organization is to improve health outcomes for patients with X-linked adrenoleukodystrophy (ALD) by empowering patients, raising awareness, and accelerating the translation of scientific advances into better clinical care.

ALD Connect’s Impressive Track Record
ALD Connect is a model of what can be accomplished when patient advocacy groups, academic researchers and physicians, and biopharmaceutical companies work together to accomplish their goals. Ben Lenail, a founder of the organization, was diagnosed in his 40s with adrenomyeloneuropathy (AMN), a late-onset phenotype of ALD. Frustrated by the lack of knowledge and options he was confronted with, Ben leveraged his own 25 years of technology and start-up experience to create ALD Connect to accelerate diagnosis and treatment of the disease and ultimately eradicate the debilitating single-gene disorder. Read More

Insights From a Patient Advocacy Summit

At the inaugural Global Genes Project 2012 Patient Advocacy Summit it was apparent that patient advocacy in the rare disease…

Tags:

zebra

Why Doctors Are Often Stumped by Rare Disorders

PharmaPhorum asked Siren Interactive to write a series of blog posts about the world of rare diseases. In the six-part…

Tags:

Crossing the Chasm of Pharma Social Media Adoption

At the end of last year, I predicted to anyone who would listen that we would cross the chasm of…

Tags:

fda-socialmedia

FDA Hearing on Social Media

Angela Romano, Content Intern at Siren Interactive, contributes this post: It finally happened — the FDA hearing on social media…

Tags:

The Digital Pharma Revolution Was Definitely Twitterized!

Okay, so I appropriated that line from someone on Twitter who, probably unknowingly, mangled the great ’70s spoken word artist…

Tags:

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com